M&A Deal Summary |
|
---|---|
Date | 2015-03-30 |
Target | Cellular Dynamics International |
Sector | Life Science |
Buyer(s) | FUJIFILM Holdings |
Deal Type | Add-on Acquisition |
Deal Value | 307M USD |
Advisor(s) | J.P. Morgan Securities (Financial) Sidley (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1934 |
Sector | Electronics |
Employees | 73,275 |
Revenue | 2.96T JPY (2023) |
FUJIFILM Holdings is the holding company of the Fujifilm Group with three operating companies, FUJIFILM Corporation, Fuji Xerox Co., Ltd. and Toyama Chemical Co., Ltd. under its umbrella. Fujifilm develops products and services in fields ranging from film and photo-taking through to photo development and printing. FUJIFILM Holdings was founded in 1934 and is based in Tokyo, Japan.
DEAL STATS | # |
---|---|
Overall | 5 of 8 |
Sector (Life Science) | 2 of 4 |
Type (Add-on Acquisition) | 4 of 5 |
State (Wisconsin) | 1 of 1 |
Country (United States) | 4 of 6 |
Year (2015) | 1 of 1 |
Size (of disclosed) | 4 of 6 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-12-15 |
SonoSite
Bothell, Washington, United States SonoSite, Inc. is a provider of hand-carried ultrasound, or HCU, systems. Sonosite specializes in the development of HCU systems for use in a variety of medical specialties in a range of clinical settings at the point-of-care. The Company's proprietary technologies have enabled Sonosite to design HCU systems that combine high resolution, all-digital, broadband imaging with advanced features and capabilities typically found on cart-based ultrasound systems. SonoSite, Inc. was formed in 1996 and is based in Bothell, Washington. |
Buy | $995M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-03-12 |
Biogen - Biologics Manufacturing Site
Hillerød, Denmark Biogen (Denmark) Manufacturing ApS is a biologics manufacturing site. Hillerød site includes a 90,000L biologics production facility with assembly, labeling and packing capabilities, quality control laboratories and warehouses. |
Buy | $890M |